'Real-World' Data Support PUL Use for LUTS

Share this content:
PUL involves placement of small permanent metallic implants into the prostate that lift the lateral lobes away from the urethra and remove obstruction.
PUL involves placement of small permanent metallic implants into the prostate that lift the lateral lobes away from the urethra and remove obstruction.

Prostatic urethral lift (PUL) procedures for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia offer symptom relief through at least 12 months of follow-up, according to “real-world data.”

PUL involves placement of small permanent metallic implants into the prostate that lift the lateral lobes away from the urethra and remove obstruction.

Paul Cozzi, MBBS, of the Sydney Urology Research Foundation in New South Wales, Australia, and colleagues analyzed pooled data from 197 commercial PUL cases performed at various centers in Australia and North America. Patients had an average age of 67 years and average prostate size of 54.1 cc. At 1, 3, and 12 months, patients had a 30%, 42%, and 31% improvement in International Prostate Symptom Score, respectively, and a 51%, 46%, and 61% improvement in quality of life, respectively. Patients experienced mild improvement in peak flow rate during the 12 months.

You must be a registered member of Renal and Urology News to post a comment.